- Supported exchanges /
- F /
- 99Z.F
MODUS THERAPEUTICS HLDG (99Z F) stock market data APIs
€0.12
0(0%)
as of October 31, 2024
Price chart is built with Anychart
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide to treat patients with sepsis, septic shock, and severe malaria conditions, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
MODUS THERAPEUTICS HLDG Financial Data Overview
| 0.12 | |
| 0.12 | |
| - | |
| 0.12 | |
| 0.12 | |
| 0.0734-0.1915 | |
| 4 306 K | |
| 35 939 K | |
| 0 | |
| 0.56 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'99Z',
Type:
'Common Stock',
Name:
'MODUS THERAPEUTICS HLDG',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'SE0015987904',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
MODUS THERAPEUTICS HLDG Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share -0.05
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get MODUS THERAPEUTICS HLDG Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get MODUS THERAPEUTICS HLDG End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
